Teleflex's vascular positioning device wins FDA nod

04/29/2013 | RTT News

The FDA has cleared Teleflex to market its ARROW VPS G4 Device, which could be released in the U.S. during the second quarter of the year. The system is said to be the only such device designed to pinpoint the exact site of the lower 1/3 of the vena cava and cavo-atrial junction using micro-Doppler ultrasound combined with advanced algorithms and intravascular ECG.

View Full Article in:

RTT News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD